Paris Saclay Cancer Cluster
Non-profit OrganizationsView the employees at
Paris Saclay Cancer Cluster-
Benjamin Garel CEO
-
Greater Paris Metropolitan Region
-
Rising Star
Raphaël Sigogne Responsable Data-
Palaiseau, ÃŽle-de-France, France
-
Rising Star
Lucie Mondoulet Director Research, Innovation & scientific valorisation in Health/Biotech, Certified Board Member-
Greater Paris Metropolitan Region
-
Top 10%
Nouzha Mohellibi Responsable Business Development- Paris-Saclay Cancer Cluster-
Top 5%
Frédéric Kurt Company Officer / Group CFO / Chief Financial Officer / VP Finance-
Paris, ÃŽle-de-France, France
-
Top 5%
Overview
As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient. 🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories. 🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities. 💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders. Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
-